DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Coiffier B, Haioun C, Ketterer N. et al.
Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study.
Blood 1998; 92: 1927-1932
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.